• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Examination of the interaction of AT2 receptor and neurotransmitter in vascular dementia

Research Project

  • PDF
Project/Area Number 24791506
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Cerebral neurosurgery
Research InstitutionEhime University

Principal Investigator

IWANAMI Jun  愛媛大学, 医学(系)研究科(研究院), 助教 (90624792)

Project Period (FY) 2012-04-01 – 2014-03-31
Keywords認知機能 / 血管性認知症 / 糖尿病 / レニン・アンジオテンシン系 / AT2受容体 / NMDA受容体
Research Abstract

Type 2 diabetes mellitus (T2DM) is reported to be associated with increased risk of dementia. We previously reported that stimulation of angiotensin II type 2 (AT2) receptor exerts brain protective effects. Accordingly, we examined the possible synergistic effect of AT2 receptor agonist, C21 and NMDA receptor antagonist, memantine on cognitive impairment in T2DM mice, KKAy. Treatment with C21 or memantine alone at these doses tended to attenuate cognitive function compared with control KKAy without significant difference. Co-administration of C21 and memantine significantly improved cognitive function. C21 treatment increased cerebral blood flow (CBF)and hippocampalfield-excitatory potential (EPSP), but memantine did not influence CBF and EPSP. Moreover, treatment with memantine increased acetylcholine levels, which was lower in KKAy compared to wild-type mice, and that C21 treatment enhanced memantine-induced acetylcholine secretion.

  • Research Products

    (5 results)

All 2014 2013 2012

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (4 results)

  • [Journal Article] Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice2013

    • Author(s)
      Iwanami J, Mogi M, Tsukuda K, Jing F, Ohshima K, Wang XL, Nakaoka H, Kan-No H, Chisaka T, Bai HY, Min LJ, Horiuchi M
    • Journal Title

      Eur J Pharmacol

      Volume: 724C Pages: 9-15

    • DOI

      10.1016/j.ejphar.2013.12.015

    • Peer Reviewed
  • [Presentation] レニン・アンジオテンシン系制御に着目した血管性認知機能障害に対する治療戦略2014

    • Author(s)
      岩波純, 茂木正樹, 堀内正嗣
    • Organizer
      第39回日本脳卒中学会
    • Place of Presentation
      大阪国際会議場, 大阪
    • Year and Date
      20140313-15
  • [Presentation] AT2 受容体刺激とNMDA 受容体調節による糖尿病性認知機能低下の改善効果2013

    • Author(s)
      岩波純, 茂木正樹, 王小俐, 佃架奈, 中岡裕智, 大島弘世, 千阪俊行, Bai Hui-Yu, 菅野晴美, 閔莉娟, 堀内正嗣
    • Organizer
      第36回日本高血圧学会総会
    • Place of Presentation
      大阪国際会議場, 大阪
    • Year and Date
      20131024-26
  • [Presentation] 糖尿病モデルマウスにおけるAT2 受容体とNMDA 受容体の相互作用による認知機能低下改善効果2012

    • Author(s)
      岩波純, 茂木正樹, 閔莉娟, 佃架奈, 景斐, 大島弘世, 堀内正嗣
    • Organizer
      第35回日本高血圧学会総会
    • Place of Presentation
      ウエスティンナゴヤキャッスル, 名古屋市
    • Year and Date
      20120920-22
  • [Presentation] 慢性脳低灌流による認知機能低下へのAT2 受容体アゴニストの効果2012

    • Author(s)
      岩波純, 茂木正樹, 閔莉娟, 佃架奈, 景斐, 大島弘世, 堀内正嗣
    • Organizer
      第35回日本高血圧学会総会
    • Place of Presentation
      ウエスティンナゴヤキャッスル, 名古屋市
    • Year and Date
      20120920-22

URL: 

Published: 2015-06-25   Modified: 2015-08-05  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi